NYSE - Delayed Quote USD
Eli Lilly and Company (LLY)
755.11
-2.28
(-0.30%)
At close: 4:00:02 PM EDT
756.50
+1.39
+(0.18%)
After hours: 7:20:52 PM EDT
Environment, Social and Governance (ESG) Risk Ratings
Total ESG Risk Score
23.6
Environmental Risk Score
2.6
Social Risk Score
13.1
Governance Risk Score
8.0
ESG Risk Score for Peers
Name | Total ESG Risk score | E | S | G |
---|---|---|---|---|
RCDTF RECORDATI | 24 | 3 | 15 | 6 |
ABBV AbbVie Inc. | 24 | 2 | 15 | 7 |
LLY Eli Lilly and Company | 24 | 3 | 13 | 8 |
BEIGF BEIGF | 23 | 4 | 14 | 6 |
ALKS Alkermes plc | 23 | 2 | 16 | 5 |
Controversy Level Sustainalytics’ Controversies Research identifies companies involved in incidents and events that may negatively impact stakeholders, the environment or the company’s operations. Controversies are rated on a scale from one to five with five denoting the most serious controversies with the largest potential impact.
Sustainalytics’ Controversies Research identifies companies involved in incidents and events that may negatively impact stakeholders, the environment or the company’s operations. Controversies are rated on a scale from one to five with five denoting the most serious controversies with the largest potential impact.
ESG data provided by Sustainalytics, Inc. Last Updated on 5/2025
LLY
Category Average
3 Significant Controversy Level
None 4 Severe
3.0 LLY
0.5 Category Average
Product Involvement Areas Flags a company’s involvement in products, services and business activities commonly used for screening purposes.
Flags a company’s involvement in products, services and business activities commonly used for screening purposes.
Products and Activities | Significant Involvement |
---|---|
Alcoholic Beverages | No |
Adult Entertainment | No |
Gambling | No |
Tobacco Products | No |
Animal Testing | Yes |
Fur and Specialty Leather | No |
Controversial Weapons | No |
Small Arms | No |
Catholic Values | No |
GMO | No |
Military Contracting | No |
Pesticides | No |
Thermal Coal | No |
Palm Oil | No |
Related Tickers
NVO Novo Nordisk A/S
67.02
+4.12%
PFE Pfizer Inc.
23.00
+0.74%
MRK Merck & Co., Inc.
77.23
+1.54%
ABBV AbbVie Inc.
185.71
+0.92%
JNJ Johnson & Johnson
152.49
+0.77%
BMY Bristol-Myers Squibb Company
47.22
+1.01%
AMGN Amgen Inc.
275.85
+1.26%
NOVO-B.CO Novo Nordisk A/S
438.70
+2.85%
GILD Gilead Sciences, Inc.
106.16
+3.57%
AZN AstraZeneca PLC
69.69
+1.28%